JAHA:孤立性收缩压或舒张压高血压年轻人慢性肾脏病风险分析

2021-04-01 MedSci原创 MedSci原创

在血压升高、1期IDH、、1期ISH、1期SDH、2期IDH、2期ISH和2期SDH的参与者发生CKD风险高于正常BP参与者。ISH和IDH组的CKD风险相似,但低于SDH组。

年轻人中高血压疾病很常见。但是,尚不清楚年轻人中孤立性收缩压高血压(ISH)、孤立性舒张压高血压(IDH)或收缩压和舒张压高血压(SDH)对慢性肾脏疾病(CKD)发生的影响。

近日,血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员纳入了2009年至2010年期间接受基础评估时未服用降压药且年龄在20至39岁之间的3030884名参与者。

参与者分类为血压正常、血压升高、1期IDH、1期ISH、1期SDH、2期IDH、2期ISH和2期SDH。该研究的主要结局是CKD事件。

该研究总共发生了5853(0.19%)例CKD事件。以正常血压为对照,血压升高参与者CKD的多变量调整风险比(HRs)(95%CI)为1.14(95%CI为1.04-1.26),1期IDH患者为1.19(95%CI为1.10–1.28);1期ISH患者为1.24(95%CI为1.08–1.42);1期SDH患者为1.39(95%CI为1.28–1.51);2期IDH患者为1.88(95%CI为1.63-2.16);2期ISH患者为1.84(95%CI为1.54–2.19);2期SDH患者为2.70(95%CI为2.44–2.98)。在体检后1年内开始接受降压治疗的患者发生CKD的HRs较未接受降压治疗患者的HRs有所降低。

由此可见,在血压升高、1期IDH、、1期ISH、1期SDH、2期IDH、2期ISH和2期SDH的参与者发生CKD风险高于正常BP参与者。ISH和IDH组的CKD风险相似,但低于SDH组。降压药可减轻年轻高血压成年人的CKD风险。

原始出处:

Eun Hui Bae.et al.Chronic Kidney Disease Risk of Isolated Systolic or Diastolic Hypertension in Young Adults: A Nationwide Sample Based‐Cohort Study.J AM HEART ASSOC.2021.https://www.ahajournals.org/doi/10.1161/JAHA.120.019764

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1840365, encodeId=dea318403657e, content=<a href='/topic/show?id=10905e20546' target=_blank style='color:#2F92EE;'>#收缩压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57205, encryptionId=10905e20546, topicName=收缩压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Mon Nov 08 07:36:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268480, encodeId=24d41268480d3, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323120, encodeId=6be8132312035, content=<a href='/topic/show?id=80ca865895e' target=_blank style='color:#2F92EE;'>#舒张压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86589, encryptionId=80ca865895e, topicName=舒张压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525654, encodeId=0af01525654e3, content=<a href='/topic/show?id=2ef14545092' target=_blank style='color:#2F92EE;'>#孤立性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45450, encryptionId=2ef14545092, topicName=孤立性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdb511649913, createdName=jxrzshh, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616214, encodeId=bad71616214e4, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953143, encodeId=41b39531436e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/2f524898202942d3b41edddb6c10e0bc/9a523954ef734369842fd56a51d959c2.jpeg, createdBy=db722323762, createdName=xuexinchao, createdTime=Thu Apr 01 19:04:15 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1840365, encodeId=dea318403657e, content=<a href='/topic/show?id=10905e20546' target=_blank style='color:#2F92EE;'>#收缩压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57205, encryptionId=10905e20546, topicName=收缩压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Mon Nov 08 07:36:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268480, encodeId=24d41268480d3, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323120, encodeId=6be8132312035, content=<a href='/topic/show?id=80ca865895e' target=_blank style='color:#2F92EE;'>#舒张压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86589, encryptionId=80ca865895e, topicName=舒张压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525654, encodeId=0af01525654e3, content=<a href='/topic/show?id=2ef14545092' target=_blank style='color:#2F92EE;'>#孤立性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45450, encryptionId=2ef14545092, topicName=孤立性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdb511649913, createdName=jxrzshh, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616214, encodeId=bad71616214e4, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953143, encodeId=41b39531436e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/2f524898202942d3b41edddb6c10e0bc/9a523954ef734369842fd56a51d959c2.jpeg, createdBy=db722323762, createdName=xuexinchao, createdTime=Thu Apr 01 19:04:15 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
    2021-04-03 zhaohui6731
  3. [GetPortalCommentsPageByObjectIdResponse(id=1840365, encodeId=dea318403657e, content=<a href='/topic/show?id=10905e20546' target=_blank style='color:#2F92EE;'>#收缩压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57205, encryptionId=10905e20546, topicName=收缩压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Mon Nov 08 07:36:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268480, encodeId=24d41268480d3, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323120, encodeId=6be8132312035, content=<a href='/topic/show?id=80ca865895e' target=_blank style='color:#2F92EE;'>#舒张压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86589, encryptionId=80ca865895e, topicName=舒张压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525654, encodeId=0af01525654e3, content=<a href='/topic/show?id=2ef14545092' target=_blank style='color:#2F92EE;'>#孤立性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45450, encryptionId=2ef14545092, topicName=孤立性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdb511649913, createdName=jxrzshh, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616214, encodeId=bad71616214e4, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953143, encodeId=41b39531436e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/2f524898202942d3b41edddb6c10e0bc/9a523954ef734369842fd56a51d959c2.jpeg, createdBy=db722323762, createdName=xuexinchao, createdTime=Thu Apr 01 19:04:15 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1840365, encodeId=dea318403657e, content=<a href='/topic/show?id=10905e20546' target=_blank style='color:#2F92EE;'>#收缩压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57205, encryptionId=10905e20546, topicName=收缩压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Mon Nov 08 07:36:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268480, encodeId=24d41268480d3, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323120, encodeId=6be8132312035, content=<a href='/topic/show?id=80ca865895e' target=_blank style='color:#2F92EE;'>#舒张压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86589, encryptionId=80ca865895e, topicName=舒张压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525654, encodeId=0af01525654e3, content=<a href='/topic/show?id=2ef14545092' target=_blank style='color:#2F92EE;'>#孤立性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45450, encryptionId=2ef14545092, topicName=孤立性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdb511649913, createdName=jxrzshh, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616214, encodeId=bad71616214e4, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953143, encodeId=41b39531436e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/2f524898202942d3b41edddb6c10e0bc/9a523954ef734369842fd56a51d959c2.jpeg, createdBy=db722323762, createdName=xuexinchao, createdTime=Thu Apr 01 19:04:15 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
    2021-04-03 jxrzshh
  5. [GetPortalCommentsPageByObjectIdResponse(id=1840365, encodeId=dea318403657e, content=<a href='/topic/show?id=10905e20546' target=_blank style='color:#2F92EE;'>#收缩压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57205, encryptionId=10905e20546, topicName=收缩压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Mon Nov 08 07:36:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268480, encodeId=24d41268480d3, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323120, encodeId=6be8132312035, content=<a href='/topic/show?id=80ca865895e' target=_blank style='color:#2F92EE;'>#舒张压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86589, encryptionId=80ca865895e, topicName=舒张压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525654, encodeId=0af01525654e3, content=<a href='/topic/show?id=2ef14545092' target=_blank style='color:#2F92EE;'>#孤立性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45450, encryptionId=2ef14545092, topicName=孤立性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdb511649913, createdName=jxrzshh, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616214, encodeId=bad71616214e4, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953143, encodeId=41b39531436e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/2f524898202942d3b41edddb6c10e0bc/9a523954ef734369842fd56a51d959c2.jpeg, createdBy=db722323762, createdName=xuexinchao, createdTime=Thu Apr 01 19:04:15 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1840365, encodeId=dea318403657e, content=<a href='/topic/show?id=10905e20546' target=_blank style='color:#2F92EE;'>#收缩压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57205, encryptionId=10905e20546, topicName=收缩压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Mon Nov 08 07:36:59 CST 2021, time=2021-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268480, encodeId=24d41268480d3, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323120, encodeId=6be8132312035, content=<a href='/topic/show?id=80ca865895e' target=_blank style='color:#2F92EE;'>#舒张压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86589, encryptionId=80ca865895e, topicName=舒张压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1525654, encodeId=0af01525654e3, content=<a href='/topic/show?id=2ef14545092' target=_blank style='color:#2F92EE;'>#孤立性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45450, encryptionId=2ef14545092, topicName=孤立性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cdb511649913, createdName=jxrzshh, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1616214, encodeId=bad71616214e4, content=<a href='/topic/show?id=9c95536521c' target=_blank style='color:#2F92EE;'>#慢性肾脏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53652, encryptionId=9c95536521c, topicName=慢性肾脏)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=305019728622, createdName=12498b08m96暂无昵称, createdTime=Sat Apr 03 09:36:59 CST 2021, time=2021-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953143, encodeId=41b39531436e, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/2f524898202942d3b41edddb6c10e0bc/9a523954ef734369842fd56a51d959c2.jpeg, createdBy=db722323762, createdName=xuexinchao, createdTime=Thu Apr 01 19:04:15 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
    2021-04-01 xuexinchao

    4

    展开4条回复

相关资讯

Stroke:慢性肾脏病是卒中患者血管周间隙增大的危险因素

在半卵圆中央区域有严重EPVS的卒中患者中CKD更为普遍。当按人种和大脑区域进行分层时,这种关系有所不同。需要进一步的研究以确认CKD与小血管疾病的亚临床指标之间的关系可能根据人种而有所不同。

Br J Dermatol:60万+人群队列研究揭示炎性皮肤病与慢性肾病风险的相关性

炎性皮肤病与慢性肾脏疾病(CKD)风险真的有关联吗

《全国非透析慢性肾脏病患者贫血风险白皮书》蓄势待发

2020年7月4日,由中关村肾病血液净化创新联盟发起的“INSIGHT-全国非透析慢性肾脏病患者贫血风险调研项目”通过网络联线的方式如期进行了启动并进行了第一次专家讨论。

停止RAS抑制剂与晚期慢性肾脏病患者的不良结局相关

尽管停止治疗与降低透析风险有关,但也与心血管事件和更高的死亡风险相关,这项研究发表在《美国肾脏病学会杂志》之上。

Hypertension:慢性肾脏病患者血压变异性和利尿剂与心血管事件的关系

在慢性肾病患者中,BPV与心血管事件和死亡相关,但与终末期肾脏疾病无关,BPV五分位数较高的利尿剂治疗组中其与心血管事件的相关性有所减弱。未来的研究应调查其他降压药是否会改变这些风险。

Clin Gastroenterology H:年纪越大,炎症性肠病患者患有慢性肾脏病的风险越低

目前尚不清楚哪些因素会影响炎症性肠病(IBD)患者患有慢性肾脏病(CKD)风险